Cargando…
Epigenetic repression of ROR2 has a Wnt-mediated, pro-tumourigenic role in colon cancer
BACKGROUND: Wnt factors control cell differentiation through semi-independent molecular cascades known as the β-catenin-dependent (canonical) and -independent (non-canonical) Wnt signalling pathways. Genetic and epigenetic alteration of components of the canonical Wnt signalling pathway is one of th...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2903502/ https://www.ncbi.nlm.nih.gov/pubmed/20591152 http://dx.doi.org/10.1186/1476-4598-9-170 |
_version_ | 1782183805471162368 |
---|---|
author | Lara, Ester Calvanese, Vincenzo Huidobro, Covadonga Fernández, Agustin F Moncada-Pazos, Ángela Obaya, Álvaro J Aguilera, Oscar González-Sancho, José Manuel Sánchez, Laura Astudillo, Aurora Muñoz, Alberto López-Otín, Carlos Esteller, Manel Fraga, Mario F |
author_facet | Lara, Ester Calvanese, Vincenzo Huidobro, Covadonga Fernández, Agustin F Moncada-Pazos, Ángela Obaya, Álvaro J Aguilera, Oscar González-Sancho, José Manuel Sánchez, Laura Astudillo, Aurora Muñoz, Alberto López-Otín, Carlos Esteller, Manel Fraga, Mario F |
author_sort | Lara, Ester |
collection | PubMed |
description | BACKGROUND: Wnt factors control cell differentiation through semi-independent molecular cascades known as the β-catenin-dependent (canonical) and -independent (non-canonical) Wnt signalling pathways. Genetic and epigenetic alteration of components of the canonical Wnt signalling pathway is one of the primary mechanisms underlying colon cancer. Despite increasing evidence of the role of the non-canonical pathways in tumourigenesis, however, the underlying molecular mechanisms are poorly understood. RESULTS: Here we report that the receptor tyrosine kinase-like orphan receptor 2 (ROR2), a transmembrane receptor for Wnt factors that activates non-canonical pathways, is frequently repressed by aberrant promoter hypermethylation in human colon cancer cell lines and primary tumours. By restoring ROR2 activity in colon cancer cells harbouring ROR2 promoter hypermethylation, we show that the role of ROR2 in colon cancer cells is mediated, at least in part, by canonical Wnt and that its epigenetic-dependent loss can be pro-tumourigenic. CONCLUSIONS: Our data show the importance of epigenetic alterations of ROR2 in colon cancer, highlighting the close interconnection between canonical and non-canonical Wnt signalling pathways in this type of tumour. |
format | Text |
id | pubmed-2903502 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-29035022010-07-14 Epigenetic repression of ROR2 has a Wnt-mediated, pro-tumourigenic role in colon cancer Lara, Ester Calvanese, Vincenzo Huidobro, Covadonga Fernández, Agustin F Moncada-Pazos, Ángela Obaya, Álvaro J Aguilera, Oscar González-Sancho, José Manuel Sánchez, Laura Astudillo, Aurora Muñoz, Alberto López-Otín, Carlos Esteller, Manel Fraga, Mario F Mol Cancer Research BACKGROUND: Wnt factors control cell differentiation through semi-independent molecular cascades known as the β-catenin-dependent (canonical) and -independent (non-canonical) Wnt signalling pathways. Genetic and epigenetic alteration of components of the canonical Wnt signalling pathway is one of the primary mechanisms underlying colon cancer. Despite increasing evidence of the role of the non-canonical pathways in tumourigenesis, however, the underlying molecular mechanisms are poorly understood. RESULTS: Here we report that the receptor tyrosine kinase-like orphan receptor 2 (ROR2), a transmembrane receptor for Wnt factors that activates non-canonical pathways, is frequently repressed by aberrant promoter hypermethylation in human colon cancer cell lines and primary tumours. By restoring ROR2 activity in colon cancer cells harbouring ROR2 promoter hypermethylation, we show that the role of ROR2 in colon cancer cells is mediated, at least in part, by canonical Wnt and that its epigenetic-dependent loss can be pro-tumourigenic. CONCLUSIONS: Our data show the importance of epigenetic alterations of ROR2 in colon cancer, highlighting the close interconnection between canonical and non-canonical Wnt signalling pathways in this type of tumour. BioMed Central 2010-06-30 /pmc/articles/PMC2903502/ /pubmed/20591152 http://dx.doi.org/10.1186/1476-4598-9-170 Text en Copyright ©2010 Lara et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Lara, Ester Calvanese, Vincenzo Huidobro, Covadonga Fernández, Agustin F Moncada-Pazos, Ángela Obaya, Álvaro J Aguilera, Oscar González-Sancho, José Manuel Sánchez, Laura Astudillo, Aurora Muñoz, Alberto López-Otín, Carlos Esteller, Manel Fraga, Mario F Epigenetic repression of ROR2 has a Wnt-mediated, pro-tumourigenic role in colon cancer |
title | Epigenetic repression of ROR2 has a Wnt-mediated, pro-tumourigenic role in colon cancer |
title_full | Epigenetic repression of ROR2 has a Wnt-mediated, pro-tumourigenic role in colon cancer |
title_fullStr | Epigenetic repression of ROR2 has a Wnt-mediated, pro-tumourigenic role in colon cancer |
title_full_unstemmed | Epigenetic repression of ROR2 has a Wnt-mediated, pro-tumourigenic role in colon cancer |
title_short | Epigenetic repression of ROR2 has a Wnt-mediated, pro-tumourigenic role in colon cancer |
title_sort | epigenetic repression of ror2 has a wnt-mediated, pro-tumourigenic role in colon cancer |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2903502/ https://www.ncbi.nlm.nih.gov/pubmed/20591152 http://dx.doi.org/10.1186/1476-4598-9-170 |
work_keys_str_mv | AT laraester epigeneticrepressionofror2hasawntmediatedprotumourigenicroleincoloncancer AT calvanesevincenzo epigeneticrepressionofror2hasawntmediatedprotumourigenicroleincoloncancer AT huidobrocovadonga epigeneticrepressionofror2hasawntmediatedprotumourigenicroleincoloncancer AT fernandezagustinf epigeneticrepressionofror2hasawntmediatedprotumourigenicroleincoloncancer AT moncadapazosangela epigeneticrepressionofror2hasawntmediatedprotumourigenicroleincoloncancer AT obayaalvaroj epigeneticrepressionofror2hasawntmediatedprotumourigenicroleincoloncancer AT aguileraoscar epigeneticrepressionofror2hasawntmediatedprotumourigenicroleincoloncancer AT gonzalezsanchojosemanuel epigeneticrepressionofror2hasawntmediatedprotumourigenicroleincoloncancer AT sanchezlaura epigeneticrepressionofror2hasawntmediatedprotumourigenicroleincoloncancer AT astudilloaurora epigeneticrepressionofror2hasawntmediatedprotumourigenicroleincoloncancer AT munozalberto epigeneticrepressionofror2hasawntmediatedprotumourigenicroleincoloncancer AT lopezotincarlos epigeneticrepressionofror2hasawntmediatedprotumourigenicroleincoloncancer AT estellermanel epigeneticrepressionofror2hasawntmediatedprotumourigenicroleincoloncancer AT fragamariof epigeneticrepressionofror2hasawntmediatedprotumourigenicroleincoloncancer |